Cargando…

Robust HIV-specific CD4(+) and CD8(+) T-cell responses distinguish elite control in adolescents living with HIV from viremic nonprogressors

BACKGROUND: Elite controllers are therapy-naive individuals living with HIV capable of spontaneous control of plasma viraemia for at least a year. Although viremic nonprogressors are more common in vertical HIV-infection than in adults’ infection, elite control has been rarely characterized in the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Vieira, Vinicius A., Millar, Jane, Adland, Emily, Muenchhoff, Maximilian, Roider, Julia, Guash, Claudia Fortuny, Peluso, Denise, Thomé, Beatriz, Garcia-Guerrero, Maria C., Puertas, Mari C., Bamford, Alasdair, Brander, Christian, Carrington, Mary, Martinez-Picado, Javier, Frater, John, Tudor-Williams, Gareth, Goulder, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654249/
https://www.ncbi.nlm.nih.gov/pubmed/34581306
http://dx.doi.org/10.1097/QAD.0000000000003078
_version_ 1784611825335140352
author Vieira, Vinicius A.
Millar, Jane
Adland, Emily
Muenchhoff, Maximilian
Roider, Julia
Guash, Claudia Fortuny
Peluso, Denise
Thomé, Beatriz
Garcia-Guerrero, Maria C.
Puertas, Mari C.
Bamford, Alasdair
Brander, Christian
Carrington, Mary
Martinez-Picado, Javier
Frater, John
Tudor-Williams, Gareth
Goulder, Philip
author_facet Vieira, Vinicius A.
Millar, Jane
Adland, Emily
Muenchhoff, Maximilian
Roider, Julia
Guash, Claudia Fortuny
Peluso, Denise
Thomé, Beatriz
Garcia-Guerrero, Maria C.
Puertas, Mari C.
Bamford, Alasdair
Brander, Christian
Carrington, Mary
Martinez-Picado, Javier
Frater, John
Tudor-Williams, Gareth
Goulder, Philip
author_sort Vieira, Vinicius A.
collection PubMed
description BACKGROUND: Elite controllers are therapy-naive individuals living with HIV capable of spontaneous control of plasma viraemia for at least a year. Although viremic nonprogressors are more common in vertical HIV-infection than in adults’ infection, elite control has been rarely characterized in the pediatric population. DESIGN: We analyzed the T-cell immunophenotype and the HIV-specific response by flow cytometry in four pediatric elite controllers (PECs) compared with age-matched nonprogressors (PNPs), progressors and HIV-exposed uninfected (HEUs) adolescents. RESULTS: PECs T-cell populations had lower immune activation and exhaustion levels when compared with progressors, reflected by a more sustained and preserved effector function. The HIV-specific T-cell responses among PECs were characterized by high-frequency Gag-specific CD4(+) T-cell activity, and markedly more polyfunctional Gag-specific CD8(+) activity, compared with PNPs and progressors. These findings were consistently observed even in the absence of protective HLA-I molecules such as HLA-B∗27/57/81. CONCLUSION: Pediatric elite control is normally achieved after years of infection, and low immune activation in PNPs precedes the increasing ability of CD8(+) T-cell responses to achieve immune control of viraemia over the course of childhood, whereas in adults, high immune activation in acute infection predicts subsequent CD8(+) T-cell mediated immune control of viremia, and in adult elite controllers, low immune activation is therefore the consequence of the rapid CD8(+) T-cell mediated immune control generated after acute infection. This distinct strategy adopted by PECs may help identify pathways that facilitate remission in posttreatment controllers, in whom protective HLA-I molecules are not the main factor.
format Online
Article
Text
id pubmed-8654249
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-86542492021-12-15 Robust HIV-specific CD4(+) and CD8(+) T-cell responses distinguish elite control in adolescents living with HIV from viremic nonprogressors Vieira, Vinicius A. Millar, Jane Adland, Emily Muenchhoff, Maximilian Roider, Julia Guash, Claudia Fortuny Peluso, Denise Thomé, Beatriz Garcia-Guerrero, Maria C. Puertas, Mari C. Bamford, Alasdair Brander, Christian Carrington, Mary Martinez-Picado, Javier Frater, John Tudor-Williams, Gareth Goulder, Philip AIDS Epidemiology and Social BACKGROUND: Elite controllers are therapy-naive individuals living with HIV capable of spontaneous control of plasma viraemia for at least a year. Although viremic nonprogressors are more common in vertical HIV-infection than in adults’ infection, elite control has been rarely characterized in the pediatric population. DESIGN: We analyzed the T-cell immunophenotype and the HIV-specific response by flow cytometry in four pediatric elite controllers (PECs) compared with age-matched nonprogressors (PNPs), progressors and HIV-exposed uninfected (HEUs) adolescents. RESULTS: PECs T-cell populations had lower immune activation and exhaustion levels when compared with progressors, reflected by a more sustained and preserved effector function. The HIV-specific T-cell responses among PECs were characterized by high-frequency Gag-specific CD4(+) T-cell activity, and markedly more polyfunctional Gag-specific CD8(+) activity, compared with PNPs and progressors. These findings were consistently observed even in the absence of protective HLA-I molecules such as HLA-B∗27/57/81. CONCLUSION: Pediatric elite control is normally achieved after years of infection, and low immune activation in PNPs precedes the increasing ability of CD8(+) T-cell responses to achieve immune control of viraemia over the course of childhood, whereas in adults, high immune activation in acute infection predicts subsequent CD8(+) T-cell mediated immune control of viremia, and in adult elite controllers, low immune activation is therefore the consequence of the rapid CD8(+) T-cell mediated immune control generated after acute infection. This distinct strategy adopted by PECs may help identify pathways that facilitate remission in posttreatment controllers, in whom protective HLA-I molecules are not the main factor. Lippincott Williams & Wilkins 2022-01-01 2021-10-01 /pmc/articles/PMC8654249/ /pubmed/34581306 http://dx.doi.org/10.1097/QAD.0000000000003078 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Epidemiology and Social
Vieira, Vinicius A.
Millar, Jane
Adland, Emily
Muenchhoff, Maximilian
Roider, Julia
Guash, Claudia Fortuny
Peluso, Denise
Thomé, Beatriz
Garcia-Guerrero, Maria C.
Puertas, Mari C.
Bamford, Alasdair
Brander, Christian
Carrington, Mary
Martinez-Picado, Javier
Frater, John
Tudor-Williams, Gareth
Goulder, Philip
Robust HIV-specific CD4(+) and CD8(+) T-cell responses distinguish elite control in adolescents living with HIV from viremic nonprogressors
title Robust HIV-specific CD4(+) and CD8(+) T-cell responses distinguish elite control in adolescents living with HIV from viremic nonprogressors
title_full Robust HIV-specific CD4(+) and CD8(+) T-cell responses distinguish elite control in adolescents living with HIV from viremic nonprogressors
title_fullStr Robust HIV-specific CD4(+) and CD8(+) T-cell responses distinguish elite control in adolescents living with HIV from viremic nonprogressors
title_full_unstemmed Robust HIV-specific CD4(+) and CD8(+) T-cell responses distinguish elite control in adolescents living with HIV from viremic nonprogressors
title_short Robust HIV-specific CD4(+) and CD8(+) T-cell responses distinguish elite control in adolescents living with HIV from viremic nonprogressors
title_sort robust hiv-specific cd4(+) and cd8(+) t-cell responses distinguish elite control in adolescents living with hiv from viremic nonprogressors
topic Epidemiology and Social
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654249/
https://www.ncbi.nlm.nih.gov/pubmed/34581306
http://dx.doi.org/10.1097/QAD.0000000000003078
work_keys_str_mv AT vieiraviniciusa robusthivspecificcd4andcd8tcellresponsesdistinguishelitecontrolinadolescentslivingwithhivfromviremicnonprogressors
AT millarjane robusthivspecificcd4andcd8tcellresponsesdistinguishelitecontrolinadolescentslivingwithhivfromviremicnonprogressors
AT adlandemily robusthivspecificcd4andcd8tcellresponsesdistinguishelitecontrolinadolescentslivingwithhivfromviremicnonprogressors
AT muenchhoffmaximilian robusthivspecificcd4andcd8tcellresponsesdistinguishelitecontrolinadolescentslivingwithhivfromviremicnonprogressors
AT roiderjulia robusthivspecificcd4andcd8tcellresponsesdistinguishelitecontrolinadolescentslivingwithhivfromviremicnonprogressors
AT guashclaudiafortuny robusthivspecificcd4andcd8tcellresponsesdistinguishelitecontrolinadolescentslivingwithhivfromviremicnonprogressors
AT pelusodenise robusthivspecificcd4andcd8tcellresponsesdistinguishelitecontrolinadolescentslivingwithhivfromviremicnonprogressors
AT thomebeatriz robusthivspecificcd4andcd8tcellresponsesdistinguishelitecontrolinadolescentslivingwithhivfromviremicnonprogressors
AT garciaguerreromariac robusthivspecificcd4andcd8tcellresponsesdistinguishelitecontrolinadolescentslivingwithhivfromviremicnonprogressors
AT puertasmaric robusthivspecificcd4andcd8tcellresponsesdistinguishelitecontrolinadolescentslivingwithhivfromviremicnonprogressors
AT bamfordalasdair robusthivspecificcd4andcd8tcellresponsesdistinguishelitecontrolinadolescentslivingwithhivfromviremicnonprogressors
AT branderchristian robusthivspecificcd4andcd8tcellresponsesdistinguishelitecontrolinadolescentslivingwithhivfromviremicnonprogressors
AT carringtonmary robusthivspecificcd4andcd8tcellresponsesdistinguishelitecontrolinadolescentslivingwithhivfromviremicnonprogressors
AT martinezpicadojavier robusthivspecificcd4andcd8tcellresponsesdistinguishelitecontrolinadolescentslivingwithhivfromviremicnonprogressors
AT fraterjohn robusthivspecificcd4andcd8tcellresponsesdistinguishelitecontrolinadolescentslivingwithhivfromviremicnonprogressors
AT tudorwilliamsgareth robusthivspecificcd4andcd8tcellresponsesdistinguishelitecontrolinadolescentslivingwithhivfromviremicnonprogressors
AT goulderphilip robusthivspecificcd4andcd8tcellresponsesdistinguishelitecontrolinadolescentslivingwithhivfromviremicnonprogressors